PHYTOTECH Medical has completed its merger with MMJ Bioscience in a move that will allow the Australian-listed group to become a farm-to-pharmaceutical medical marijuana company.
THE re-branded MMJ PhytoTech Limited will control the complete supply chain from cultivation to distribution after Phytotech raised $4.8 million in an oversubscribed shareholder placement to acquire MMJ.
The company expects to process medical grade marijuana from its Canadian operations into pill form for the European markets.